Form 4 for EW Edwards Lifesciences
Accepted 2024-05-30 00:00:00 ET · period of report 2024-05-30 · accession 0001225208-24-006448 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-05-30 | 2024-05-30 | EW | Zovighian Bernard J | CEO, Dir | S - Sale | $87.68 | -8,617 | 68.2K | -11% | -$755.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-30 | S | D | 8,617 | $87.68 | 68,217.90 | D | — | — |